For Color's employer health programs, should we emphasize individual genetic insights or population-level health trends to maximize impact?

Introduction

The trade-off between emphasizing individual genetic insights or population-level health trends for Color's employer health programs is a critical decision that will shape our product strategy and impact. This scenario involves balancing personalized health information with broader, data-driven insights to maximize the effectiveness of our employer health programs. I'll analyze this trade-off by examining the product context, identifying key metrics, designing experiments, and providing a structured decision framework.

Step 1

Clarifying Questions (3 minutes)

• Context: I'm thinking our employer health programs are a key revenue driver. Could you confirm if this is a primary business line or a newer initiative we're exploring?

Why it matters: Helps prioritize resources and align with overall business strategy Expected answer: Primary business line Impact on approach: Would justify significant investment in whichever direction we choose

• Business Context: Based on current market trends, I assume we're facing increased competition in the employer health space. How does this trade-off align with our competitive differentiation strategy?

Why it matters: Informs how we position our product in the market Expected answer: Seeking unique value proposition Impact on approach: May lean towards a hybrid model that leverages both individual and population insights

• User Impact: I'm guessing our user base includes both health-conscious individuals and those less engaged with their health. Can you share the breakdown of our current user engagement levels?

Why it matters: Helps tailor our approach to maximize user adoption and impact Expected answer: Mixed engagement levels Impact on approach: Might suggest a phased rollout or personalized user journeys

• Technical Feasibility: Considering the sensitive nature of genetic data, I assume we have robust data protection measures in place. Can you confirm our current capabilities for securely handling individual genetic data at scale?

Why it matters: Ensures we can deliver on whichever option we choose Expected answer: Strong data protection, some scalability challenges Impact on approach: May influence the timeline and resources needed for implementation

• Resource Allocation: Given the potential impact of this decision, I'm thinking this might require a dedicated cross-functional team. What resources are currently allocated to this initiative?

Why it matters: Determines the scope and speed of implementation Expected answer: Limited resources available Impact on approach: Might suggest a phased approach or prioritizing one aspect initially